Pharmacogenomics Market Forecast to 2028

Report Code : TIPRE00007564 | Region : Global | Industry : Pharmaceuticals | Published Date : 17/Feb/2022
Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)

The pharmacogenomics market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is estimated to grow at a CAGR of 10.3% from 2021 to 2028. Several factors such as the increasing prevalence of chronic diseases, rising demand for precision medicine, and the growing funding for pharmacogenomic research activities boost the market growth. However, the lack of skilled professionals hampers the market growth.

Pharmacogenomics (Pharmacogenetics) is the study of the role of genes in manipulating the activity of drugs, which assists the researchers in predicting the drug response to develop personalized medicines. It involves proactive testing of single or multiple genes to improve the therapeutic response of treatments and reduce the severity of adverse events. Pharmacogenomic technologies also have the potential to reduce the overall cost of the treatment.

Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is further segmented into standard PCR, real-time PCR, and digital PCR. The PCR segment held the largest share of 37.71% of the pharmacogenomics market in 2021. Based on application, the pharmacogenomics market is segmented into drug discovery, oncology, neurology and psychiatry, pain management, cardiovascular diseases, and others. The oncology segment accounted for the largest market share in 2021, whereas the drug discovery segment is expected to register the highest CAGR in the market during the forecast period.

Based on end user, the pharmacogenomics market has been segmented into hospitals and clinics, biopharmaceutical companies, CROs and CDMOs, and others. The CROs and CDMOs segment accounted for the largest market share in 2021. However, the hospitals and clinics segment is expected to register the highest CAGR in the market during the forecast period.

National Centre of Excellence in Genomic Medicine Research, World Health Organization, Indian Council of Medical Research, and National Center for Health Statistics are among the primary and secondary sources referred to while preparing the pharmacogenomics market report.

The List of Companies - Pharmacogenomics Market

1. F. Hoffmann-la Roche Ltd

2. Abbott

3. Oxford Nanopore Technologies

4. Thermo Fisher Scientific Inc.

5. Illumina, Inc.

6. QIAGEN

7. Agilent Technologies, Inc.

8. Myriad Genetics, Inc.

9. Admera Health

10. Dynamic DNA Laboratories

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Pharmacogenomics Market – By Technology

1.3.2 Global Pharmacogenomics Market – By Application

1.3.3 Global Pharmacogenomics Market – By End User

1.3.4 Global Pharmacogenomics Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Pharmacogenomics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Pharmacogenomics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Chronic Diseases

5.1.2 Growing Funding for Pharmacogenomics

5.2 Market Restraints

5.2.1 Lack of Skilled Professionals

5.3 Market Opportunities

5.3.1 Increasing Demand for Third Generation Sequencing

5.4 Future Trends

5.4.1 Increasing Demand for Personalized Medicines

6. Pharmacogenomics Market– Global Analysis

6.1 Global Pharmacogenomics Market Revenue Forecast and Analysis

6.2 Global Pharmacogenomics Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Pharmacogenomics Market Revenue and Forecasts To 2028 – Technology

7.1 Overview

7.2 Global Pharmacogenomics Market Share by Technology - 2021 & 2028 (%)

7.3 Polymerase Chain Reaction

7.3.1 Overview

7.3.2 Polymerase Chain Reaction: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.3 Real Time PCR

7.3.3.1 Overview

7.3.3.2 Real Time PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.4 Standard PCR

7.3.4.1 Overview

7.3.4.2 Standard PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.3.5 Digital PCR

7.3.5.1 Overview

7.3.5.2 Digital PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.4 Sequencing

7.4.1 Overview

7.4.2 Sequencing: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.5 Microarray

7.5.1 Overview

7.5.2 Microarray: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.6 Gel Electrophoresis

7.6.1 Overview

7.6.2 Gel Electrophoresis: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.7 Mass Spectrometry

7.7.1 Overview

7.7.2 Mass Spectrometry: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8. Global Pharmacogenomics Market Revenue and Forecasts To 2028– by Application

8.1 Overview

8.2 Global Pharmacogenomics Market Share by Application- 2021 & 2028 (%)

8.3 Drug Discovery

8.3.1 Overview

8.3.2 Drug Discovery: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Oncology

8.4.1 Overview

8.4.2 Oncology: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology & Psychiatry

8.5.1 Overview

8.5.2 Neurology & Psychiatry: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.6 Pain Management

8.6.1 Overview

8.6.2 Pain Management: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.7 Cardiovascular Disease

8.7.1 Overview

8.7.2 Cardiovascular Disease: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9. Pharmacogenomics Market Revenue and Forecasts To 2028 – End User

9.1 Overview

9.2 Global Pharmacogenomics Market Share by End User - 2021 & 2028 (%)

9.3 Hospitals and Clinics

9.3.1 Overview

9.3.2 Hospitals and Clinics: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Biopharmaceutical Companies

9.4.1 Overview

9.4.2 Biopharmaceuticals Companies: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.5 CROs and CDMOs

9.5.1 Overview

9.5.2 CROs and CDMOs: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)

10. Pharmacogenomics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 North America: Pharmacogenomics Market

10.1.1 Overview

10.1.2 North America: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: Pharmacogenomics Market, by Technology, 2019–2028 (US$ Million)

10.1.3.1 North America: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.4 North America: Pharmacogenomics Market, by Application, 2019–2028 (US$ Million)

10.1.5 North America: Pharmacogenomics Market, by End-User, 2019–2028 (US$ Million)

10.1.6 North America: Pharmacogenomics Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 Overview

10.1.6.1.2 US: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3 US: Pharmacogenomics Market, by Technology, 2019–2028 (US$ Million)

10.1.6.1.3.1 US: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.1.4 US: Pharmacogenomics Market, by Application, 2019–2028 (US$ Million)

10.1.6.1.5 US: Pharmacogenomics Market, by End-User, 2019–2028 (US$ Million)

10.1.6.2 Canada: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Overview

10.1.6.2.2 Canada: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3 Canada: Pharmacogenomics Market, by Technology, 2019–2028 (US$ Million)

10.1.6.2.3.1 Canada: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.2.4 Canada: Pharmacogenomics Market, by Application, 2019–2028 (US$ Million)

10.1.6.2.5 Canada: Pharmacogenomics Market, by End-User, 2019–2028 (US$ Million)

10.1.6.3 Mexico: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Overview

10.1.6.3.2 Mexico: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3 Mexico: Pharmacogenomics Market, by Technology, 2019–2028 (US$ Million)

10.1.6.3.3.1 Mexico: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.1.6.3.4 Mexico: Pharmacogenomics Market, by Application, 2019–2028 (US$ Million)

10.1.6.3.5 Mexico: Pharmacogenomics Market, by End-User, 2019–2028 (US$ Million)

10.2 Europe: Pharmacogenomics Market

10.2.1 Overview

10.2.2 Europe: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.3.1 Europe: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.2.4 Europe: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.5 Europe: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6 Europe: Pharmacogenomics Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.1 Overview

10.2.6.1.2 Germany: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.3 Germany: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.3.1 Germany: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.2.6.1.4 Germany: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.5 Germany: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2 France: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.1 Overview

10.2.6.2.2 France: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.3 France: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.3.1 France: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.2.6.2.4 France: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.5 France: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3 UK: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.1 Overview

10.2.6.3.2 UK: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.3 UK: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.3.1 UK: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.2.6.3.4 UK: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.5 UK: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4 Italy: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.1 Overview

10.2.6.4.2 Italy: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.3 Italy: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.3.1 Italy: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.2.6.4.4 Italy: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.5 Italy: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5 Spain: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.1 Overview

10.2.6.5.2 Spain: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.3 Spain: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.3.1 Spain: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.2.6.5.4 Spain: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.5 Spain: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6 Rest of Europe: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.1 Overview

10.2.6.6.2 Rest of Europe: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.3 Rest of Europe: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.3.1 Rest of Europe: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.2.6.6.4 Rest of Europe: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.5 Rest of Europe: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.3 Asia Pacific Pharmacogenomics Market Revenue and Forecasts To 2028

10.3.1 Overview

10.3.2 Asia Pacific Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.3 Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.3.3.1 Asia Pacific: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.3.4 Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.5 Asia Pacific: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.3.6 Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)

10.3.6.1 Japan: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.1.1 Overview

10.3.6.1.2 Japan: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.1.3 Japan: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.3.6.1.3.1 Japan: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.3.6.1.4 Japan: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.1.5 Japan: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.3.6.2 China: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.2.1 Overview

10.3.6.2.2 China: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.2.3 China: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.3.6.2.3.1 China: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.3.6.2.4 China: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.2.5 China: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.3.6.3 India Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.3.1 Overview

10.3.6.3.2 India: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.3.3 India: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.3.6.3.3.1 India: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.3.6.3.4 India: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.3.5 India: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.3.6.4 South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.4.1 Overview

10.3.6.4.2 South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.4.3 South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.3.6.4.3.1 South Korea: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.3.6.4.4 South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.4.5 South Korea: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.3.6.5 Australia: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.5.1 Overview

10.3.6.5.2 Australia: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.5.3 Australia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.3.6.5.3.1 Australia: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.3.6.5.4 Australia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.5.5 Australia: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6 Rest of Asia Pacific: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.1 Overview

10.3.6.6.2 Rest of Asia Pacific: Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.3 Rest of Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.3.6.6.3.1 Rest of Asia Pacific: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million) 131

10.3.6.6.4 Rest of Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.6.5 Rest of Asia Pacific: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4 Middle East & Africa Pharmacogenomics Market Revenue and Forecasts To 2028

10.4.1 Overview

10.4.2 Middle East & Africa Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.3 Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.4.3.1 Middle East & Africa: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.4.4 Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.4.5 Middle East & Africa: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4.6 Middle East & Africa Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)

10.4.6.1 UAE: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.1.1 Overview

10.4.6.1.2 UAE: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.1.3 UAE: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.4.6.1.3.1 UAE: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.4.6.1.4 UAE: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.1.5 UAE: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2 Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.2.1 Overview

10.4.6.2.2 Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.2.3 Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.4.6.2.3.1 Saudi Arabia: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.4.6.2.4 Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.2.5 Saudi Arabia: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3 South Africa: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.3.1 Overview

10.4.6.3.2 South Africa Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.3.3 South Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.4.6.3.3.1 South Africa: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.4.6.3.4 South Africa: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.3.5 South Africa: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4 Rest of Middle East and Africa: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.4.1 Overview

10.4.6.4.2 Rest of Middle East and Africa: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.4.3 Rest of Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.4.6.4.3.1 Rest of Middle East & Africa: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.4.6.4.4 Rest of Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.4.5 Rest of Middle East and Africa: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.5 South And Central America Pharmacogenomics Market Revenue and Forecasts To 2028

10.5.1 Overview

10.5.2 South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.5.3 South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.5.3.1 South and Central America: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.5.4 South and Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.5.5 South and Central America: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.5.6 South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)

10.5.6.1 Argentina Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.1.1 Overview

10.5.6.1.2 Argentina Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.1.3 Argentina: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.5.6.1.3.1 Argentina: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.5.6.1.4 Argentina: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.5.6.1.5 Argentina: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2 Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.2.1 Overview

10.5.6.2.2 Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.2.3 Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.5.6.2.3.1 Brazil: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.5.6.2.4 Brazil: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.5.6.2.5 Brazil: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3 Rest of South and Central America: Pharmacogenomics Market– Revenue and Forecast to 2028 (USD Mn)

10.5.6.3.1 Overview

10.5.6.3.2 Rest of South and Central America: Pharmacogenomics Market– Revenue and Forecast to 2028 (USD Mn)

10.5.6.3.3 Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.5.6.3.3.1 Rest of South & Central America: Pharmacogenomics Market, by PCR, 2019–2028 (US$ Million)

10.5.6.3.4 Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.5.6.3.5 Rest of South and Central America: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

11. Impact of COVID-19 Pandemic on Global Pharmacogenomics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Pharmacogenomics Market

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts 176

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Oxford Nanopore Technologies

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Illumina, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 QIAGEN

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Myriad Genetics, Inc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Admera Health

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Dynamic DNA Laboratories

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners 205

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 4. US Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 5. US Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 6. US Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 7. US Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 12. Mexico: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 13. Mexico: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 14. Mexico Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 15. Mexico Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Europe: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 17. Europe: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 18. Europe: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 19. Europe: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 20. Germany: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 21. Germany: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 22. Germany: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 23. Germany: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 24. France: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 25. France: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 26. France: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 27. France: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 28. UK: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 29. UK: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 30. UK: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 31. UK: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 32. Italy: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 33. Italy: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 34. Italy: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 35. Italy: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 36. Spain: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 37. Spain: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 38. Spain: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 39. Spain: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 40. Rest of Europe: Pharmacogenomics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 41. Rest of Europe: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 42. Rest of Europe: Pharmacogenomics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 43. Rest of Europe: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 44. Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million).

Table 45. Asia Pacific: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 46. Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 47. Asia Pacific: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 48. Japan: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 49. Japan: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 50. Japan: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 51. Japan: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 52. China: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 53. China: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 54. China: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 55. China: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 56. India: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 57. India: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 58. India: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 59. India: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 60. South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 61. South Korea: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 62. South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 63. South Korea: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 64. Australia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 65. Australia: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 66. Australia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 67. Australia: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 68. Rest of Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 69. Rest of Asia Pacific: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 70. Rest of Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 71. Rest of Asia Pacific: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 72. Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 73. Middle East & Africa: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 74. Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 75. Middle East & Africa: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 76. UAE: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 77. UAE: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 78. UAE: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 79. UAE: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 80. Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 81. Saudi Arabia: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 82. Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 83. Saudi Arabia: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 84. South Africa Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 85. South Africa: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 86. South Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 87. South Africa: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 88. Rest of Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 89. Rest of Middle East & Africa: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 90. Rest of Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 91. Rest of Middle East and Africa: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 92. South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 93. South and Central America: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 94. South and Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 95. South and Central America: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 96. Argentina: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 97. Argentina: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 98. Argentina: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 99. Argentina: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 100. Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 101. Brazil: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 102. Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 103. Brazil: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 104. Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 105. Rest of South & Central America: Pharmacogenomics Market, by PCR– Revenue and Forecast to 2028 (US$ Million)

Table 106. Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 107. Rest of South and Central America: Pharmacogenomics Market, by End-User – Revenue and Forecast to 2028 (US$ Million)

Table 108. Organic Developments Done By Companies

Table 109. Inorganic Developments Done By Companies

Table 110. Glossary of Terms

The List of Companies - Pharmacogenomics Market

1. F. Hoffmann-la Roche Ltd

2. Abbott

3. Oxford Nanopore Technologies

4. Thermo Fisher Scientific Inc.

5. Illumina, Inc.

6. QIAGEN

7. Agilent Technologies, Inc.

8. Myriad Genetics, Inc.

9. Admera Health

10. Dynamic DNA Laboratories

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the pharmacogenomics market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global Intradermal Injection market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distributions.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Pharmacogenomics Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry